Zika-Specific Immune Response
2 clinical trials · Condition
◉ Watch Zika-Specific Immune Response
| Record | Firm | Date |
|---|---|---|
| VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults (NCT02996461) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-12 |
| Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults (NCT02840487) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-02 |
Track Zika-Specific Immune Response automatically
Every clearance here is in the API, with alerts when new ones post.